🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kohei Shitara

National Cancer Center Hospital East

ORCID: 0000-0001-5196-3630
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Pembrolizumab in HER2-Positive Gastric Cancer”.

Pembrolizumab in HER2-Positive Gastric Cancer

New England Journal of Medicine(2024)10.1056/nejmc2408121
N/A
1.4DataRank · unranked
65 citations

Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Jean Phillipe Metges +21 more

Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies

Nature Communications(2025)10.1038/s41467-025-65148-6
N/A
0.472DataRank · unranked
15 citations

Keiko Takahashi, Naoya Sakamoto, Martina De Vizio, Micaela Morgado, Shahryar Khoshtinat Nikkhoi +17 more

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Journal of Clinical Oncology(2025)10.1200/jco.24.00055
N/A
0.457DataRank · unranked
20 citations

Kohei Shitara, Katrin Marie Sjoquist, Andrew Martin, Anthony Jaworski, Niall C. Tebbutt +16 more

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials

Journal of Clinical Oncology(2025)10.1200/jco-25-01003
N/A
0.385DataRank · unranked
12 citations

Beatrice Borelli, Tadayoshi Hashimoto, Yoshiaki Nakamura, Simone Oldani, Francesca Battaglin +17 more

Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102378
N/A
0DataRank · unranked
170 citations

Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai +9 more

473P A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)

Annals of Oncology(2021)10.1016/j.annonc.2021.08.994
N/A
0DataRank · unranked
1 citations

Satoru Iwasa, Kohei Shitara, Takafumi Koyama, Yujiro Ueda, Satoshi Nagao +7 more

Global alliances in translational cancer research

Cancer Cell(2025)10.1016/j.ccell.2025.02.005
N/A
0DataRank · unranked
0 citations

Yun‐Xin Lu, Kohei Shitara, Heinz-Josef Lenz, Rui-Hua Xu, Hui Luo